Paul B Manning

VRCA

Paul B Manning serves as director at Verrica Pharmaceuticals Inc. (VRCA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

22 trades

$88.45M

Total Sells

1 trades

$18.96M

Net Position

Net Buyer

$69.49M

Companies Traded

CADL, VRCA, LQDA, TSHA

Active Period

Mar 2021 – Feb 2026

23 total trades

Most Recent

Buy CADL

Feb 26, 2026 · $3.00M

Paul B Manning's Insider Trading at Verrica Pharmaceuticals Inc. (VRCA)

Buys

5 · $39.89M

Sells

0 · $0.00

Total Shares Bought

9,877,876

Total Shares Sold

VRCA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 25, 2025	Buy	4,126,142	$4.24	$17.51M	0
Jul 24, 2023	Buy	200,000	$5.02	$1.00M	7,851,128
Jul 5, 2022	Buy	4,761,904	$2.10	$10.00M	13,651,128
Dec 6, 2021	Buy	50,000	$9.36	$467.9K	8,149,394
Mar 29, 2021	Buy	739,830	$14.75	$10.91M	739,830

Paul B Manning's Insider Trading at Liquidia Corporation (LQDA)

Buys

4 · $7.50M

Sells

1 · $18.96M

Total Shares Bought

1,206,977

Total Shares Sold

670,837

LQDA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 28, 2025	Sell	670,837	$28.26	$18.96M	0
Sep 16, 2024	Buy	337,078	$8.90	$3.00M	816,311
Dec 18, 2023	Buy	279,330	$7.16	$2.00M	279,330
Apr 19, 2022	Buy	392,156	$5.10	$2.00M	392,156
Apr 15, 2021	Buy	198,413	$2.52	$500.0K	737,646

Paul B Manning's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

9 · $25.15M

Sells

0 · $0.00

Total Shares Bought

20,385,804

Total Shares Sold

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 30, 2025	Buy	750,000	$2.75	$2.06M	0
Jul 1, 2024	Buy	1,333,333	$2.25	$3.00M	1,333,333
Nov 20, 2023	Buy	100,000	$1.63	$163.0K	16,566,667
Aug 16, 2023	Buy	16,466,667	$0.90	$14.82M	16,466,667
Nov 2, 2022	Buy	1,500,000	$2.00	$3.00M	1,642,202
Feb 4, 2022	Buy	201,602	$7.80	$1.57M	2,091,704
Nov 29, 2021	Buy	2,202	$13.19	$29.0K	34,202
Nov 24, 2021	Buy	20,000	$12.54	$250.8K	32,000
May 17, 2021	Buy	12,000	$20.98	$251.8K	12,000

Paul B Manning's Insider Trading at Candel Therapeutics, Inc. (CADL)

Buys

3 · $10.91M

Sells

0 · $0.00

Total Shares Bought

1,856,458

Total Shares Sold

CADL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 26, 2026	Buy	550,458	$5.45	$3.00M	2,763,527
Dec 16, 2024	Buy	1,250,000	$6.00	$7.50M	0
Jul 27, 2021	Buy	56,000	$7.34	$410.8K	0

Paul B Manning's Insider Trading at Acumen Pharmaceuticals, Inc. (ABOS)

Buys

1 · $5.00M

Sells

0 · $0.00

Total Shares Bought

312,500

Total Shares Sold

ABOS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 8, 2021	Buy	312,500	$16.00	$5.00M	3,352,693

Related Insiders

JEFFS ROGER

director, officer: Chief Executive Officer

LQDASell · Apr 21, 2026

Michael Kaseta

officer: CFO and COO

LQDASell · Apr 16, 2026

Jason Adair

officer: Chief Business Officer

LQDASell · Apr 14, 2026

Dana Boyle

officer: Chief Accounting Officer

LQDASell · Apr 14, 2026

Sarah Krepp

officer: Chief Human Resource Officer

LQDASell · Apr 14, 2026

Scott Moomaw

officer: Chief Commercial Officer

LQDASell · Apr 14, 2026

Rajeev Saggar

officer: Chief Medical Officer

LQDASell · Apr 14, 2026

Russell Schundler

officer: General Counsel

LQDASell · Apr 14, 2026

Explore More Insider Trading Data

VRCA Insider Trading Activity

View all insider trades at Verrica Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity